The COVID-19 pandemic has had a significant impact on the entire planet. Due to huge disparities in Latin American nations with limited access to health care and high poverty, their populations may be among the most adversely afflicted. Patients with chronic illnesses, such as rheumatic diseases, are particularly susceptible due to the increased likelihood of flare-ups and consequent poor outcomes. Furthermore, misuse of antimalarials for COVID-19 therapy may result in shortages in our region. 

Telemedicine, the use of personal protective equipment by patients and providers, web conferences, and comprehensive care are all tools that will help to reduce the risk of infections and other complications in rheumatoid arthritis patients while also improving the knowledge and experience of rheumatologists worldwide.